Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations

American Journal of Epidemiology

Volumn 163, Issue 4, 2006, Pages 300-309

  Trikalinos, Thomas A ^a,b   Salanti, Georgia ^c,d   Khoury, Muin J ^e   Ioannidis, John P A ^a,b,f  

^a UNIVERSITY OF IOANNINA   (Greece)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

^d Cambridge Genetics Knowledge Park   (United Kingdom)

^e NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^f INSTITUTE OF COMPUTER SCIENCE   (Greece)

Author keywords

Association; Bias (epidemiology); Genes; Genetics; Meta analysis

Indexed keywords

DISEASE PREVALENCE; GENETIC ANALYSIS;

ARTICLE; COMPUTER PROGRAM; DATA BASE; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LUNG CANCER; MATHEMATICAL MODEL; NEURAL TUBE DEFECT; PARKINSON DISEASE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; THROMBOEMBOLISM;

BIAS (EPIDEMIOLOGY); DATABASES, GENETIC; GENETIC HETEROGENEITY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MODELS, STATISTICAL; POLYMORPHISM, GENETIC; REPRODUCIBILITY OF RESULTS;

EID: 32544442291     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwj046     Document Type: Article

References (69)

1. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994;265:2037-48.
2. Khoury MJ, Little J. Human genome epidemiologic reviews: the beginning of something HuGE. Am J Epidemiol 2000; 151:2-3.
3. Ioannidis JP, Ntzani EE, Trikalinos TA, et al. Replication validity of genetic association studies. Nat Genet 2001;29:306-9.
4. Hirschhorn JN, Lohmueller K, Byrne E, et al. A comprehensive review of genetic association studies. Genet Med 2002;4:45-61.
5. Little J, Khoury MJ, Bradley L, et al. The human genome project is complete. How do we develop a handle for the pump? Am J Epidemiol 2003;157:667-73.
6. Easterbrook PJ, Berlin JA, Gopalan R, et al. Publication bias in clinical research. Lancet 1991;337:867-72.
7. Ioannidis JP, Trikalinos TA, Ntzani EE, et al. Genetic associations in large versus small studies: an empirical assessment. Lancet 2003;361:567-71.
8. Ioannidis JP, Ntzani EE, Trikalinos TA. 'Racial' differences in genetic effects for complex diseases. Nat Genet 2004;36:1312-18.
9. Lohmueller KE, Pearce CL, Pike M, et al. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003;33:177-82.
10. Khoury MJ, Beaty TH, Cohen BH, eds. Fundamentals of genetic epidemiology. New York, NY: Oxford University Press, 1993.
11. Mitchell AA, Cutler DJ, Chakravarti A. Undetected genotyping errors cause apparent overtransmission of common alleles in the transmission/disequilibrium test. Am J Hum Genet 2003;72:598-610.
12. Hosking L, Lumsden S, Lewis K, et al. Detection of genotyping errors by Hardy-Weinberg equilibrium testing. Eur J Hum Genet 2004;12:395-9.
13. Bardoczy Z, Gyorffy B, Kocsis I, et al. Re-calculated Hardy-Weinberg values in papers published in Atherosclerosis between 1995 and 2003. Atherosclerosis 2004;173:141-3.
14. Salanti G, Amountza G, Ntzani EE, et al. Hardy-Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power. Eur J Hum Genet 2005;13:840-8.
15. Shoemaker J, Painter I, Weir BS. A Bayesian characterization of Hardy-Weinberg disequilibrium. Genetics 1998;149:2079-88.
16. Emigh T. A comparison of tests for Hardy-Weinberg equilibrium. Biometrics 1980;36:627-42.
17. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
18. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med 1997;127:820-6.
19. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
20. Cappelleri JC, Ioannidis JP, Schmid CH, et al. Large trials vs meta-analysis of smaller trials: how do their results compare? JAMA 1996;276:1332-8.
21. Schaid DJ, Jacobsen SJ. Biased tests of association: comparisons of allele frequencies when departing from Hardy-Weinberg proportions. Am J Epidemiol 1999;149:706-11.
22. Lathrop MG. Estimating genotype relative risks. Tissue Antigens 1983;22:160-6.
23. Noble EP. The D2 dopamine receptor gene: a review of association studies in alcoholism and phenotypes. Alcohol 1998; 16:33-45.
24. Sharma P. Meta-analysis of the ACE gene in ischaemic stroke. J Neurol Neurosurg Psychiatry 1998;64:227-30.
25. Botto LD, Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 2000;151:862-77.
26. Hinney A, Remschmidt H, Hebebrand J. Candidate gene polymorphisms in eating disorders. Eur J Pharmacol 2000;410:147-59.
27. Mizuta I, Mizuta E, Yamasaki S, et al. Meta-analysis of polymorphism of the catechol-O-methyltransferase gene in relation to the etiology of Parkinson's disease in Japan. Mov Disord 2000;15:1013-14.
28. Di Castelnuovo A, de Gaetano G, Donati MB, et al. Platelet glycoprotein receptor IIIa polymorphism PLA1/PLA2 and coronary risk: a meta-analysis. Thromb Haemost 2001;85:626-33.
29. Efstathiadou Z, Tsatsoulis A, Ioannidis JP. Association of collagen Ialpha 1 Sp1 polymorphism with the risk of prevalent fractures: a meta-analysis. J Bone Miner Res 2001;16:1586-92.
30. Schena FP, D'Altri C, Cerullo G, et al. ACE gene polymorphism and IgA nephropathy: an ethnically homogeneous study and a meta-analysis. Kidney Int 2001;60:732-40.
31. Trikalinos TA, Karassa FB, Ioannidis JP. Meta-analysis of the association between low-affinity Fcgamma receptor gene polymorphisms and hematologic and autoimmune disease. (Letter). Blood 2001;98:1634-5.
32. Bonnici F, Keavney B, Collins R, et al. Angiotensin converting enzyme insertion or deletion polymorphism and coronary restenosis: meta-analysis of 16 studies. BMJ 2002;325:517-20.
33. Feyler A, Voho A, Bouchardy C, et al. Point: myeloperoxidase-463G → a polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:1550-4.
34. Karassa FB, Trikalinos TA, Ioannidis JP, et al. Role of the Fcgamma receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis. Arthritis Rheum 2002;46:1563-71.
35. Karassa FB, Bijl M, Davies KA, et al. Role of the Fcgamma receptor IIA polymorphism in the antiphospholipid syndrome: an international meta-analysis. Arthritis Rheum 2003;48:1930-8.
36. Karassa FB, Trikalinos TA, Ioannidis JP, et al. The Fc gamma RIIIA-F158 allele is a risk factor for the development of lupus nephritis: a meta-analysis. Kidney Int 2003;63:1475-82.
37. Ray JG, Shmorgun D, Chan WS. Common C677T polymorphism of the methylenetetrahydrofolate reductase gene and the risk of venous thromboembolism: meta-analysis of 31 studies. Pathophysiol Haemost Thromb 2002;32:51-8.
38. Anguelova M, Benkelfat C, Turecki G. A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: II. Suicidal behavior. Mol Psychiatry 2003;8:646-53.
39. Jonsson EG, Flyckt L, Burgert E, et al. Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis. Psychiatr Genet 2003;13:1-12.
40. Kehoe PG, Katzov H, Feuk L, et al. Haplotypes extending across ACE are associated with Alzheimer's disease. Hum Mol Genet 2003;12:859-67.
41. Kosmas IP, Tatsioni A, Ioannidis JP. Association of Leiden mutation in factor V gene with hypertension in pregnancy and pre-eclampsia: a meta-analysis. J Hypertens 2003;21:1221-8.
42. Kosmas IP, Tatsioni A, Ioannidis JP. Association of C677T polymorphism in the methylenetetrahydrofolate reductase gene with hypertension in pregnancy and pre-eclampsia: a meta-analysis. J Hypertens 2004;22:1655-62.
43. Matakidou A, Eisen T, Houlston RS. TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis. Mutagenesis 2003;18:377-85.
44. Nielsen EM, Hansen L, Carstensen B, et al. The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes. Diabetes 2003;52:573-7.
45. Ntais C, Polycarpou A, Ioannidis JP. Association of the CYP17 gene polymorphism with the risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2003;12:120-6.
46. Ntais C, Polycarpou A, Ioannidis JP. SRD5A2 gene polymorphisms and the risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2003;12:618-24.
47. Ntais C, Polycarpou A, Ioannidis JP. Vitamin D receptor gene polymorphisms and risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2003;12:1395-402.
48. Ntais C, Polycarpou A, Ioannidis JP. Meta-analysis of the association of the Cathepsin D Ala224Val gene polymorphism with the risk of Alzheimer's disease: a HuGE gene-disease association review. Am J Epidemiol 2004;159:527-36.
49. Sethi AA, Nordestgaard BG, Tybjaerg-Hansen A. Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a meta-analysis. Arterioscler Thromb Vasc Biol 2003;23:1269-75.
50. Maraganore DM, Lesnick TG, Elbaz A, et al. UCHL1 is a Parkinson's disease susceptibility gene. Ann Neurol 2004;55:512-21.
51. Pasche B, Kaklamani V, Hou N, et al. TGFBR1*6A and cancer: a meta-analysis of 12 case-control studies. (Letter). J Clin Oncol 2004;22:756-8.
52. Wheeler JG, Keavney BD, Watkins H, et al. Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies. Lancet 2004;363:689-95.
53. Gyorffy B, Kocsis I, Vasarhelyi B. Biallelic genotype distributions in papers published in Gut between 1998 and 2003: altered conclusions after recalculating the Hardy-Weinberg equilibrium. (Letter). Gut 2004;53:614-15.
54. Gyorffy B, Kocsis I, Vasarhelyi B. Missed calculations and new conclusions: re-calculation of genotype distribution data published in Journal of Investigative Dermatology, 1998-2003. (Letter). J Invest Dermatol 2002;122:644-6.
55. Kocsis I, Gyorffy B, Nemeth E, et al. Examination of Hardy-Weinberg equilibrium in papers of Kidney International: an underused tool. Kidney Int 2004;65:1956-8.
56. Kocsis I, Vasarhelyi B, Gyorffy A, et al. Reanalysis of genotype distributions published in Neurology between 1999 and 2002. Neurology 2004;63:357-8.
57. Pritchard JK, Stephens M, Rosenberg NA, et al. Association mapping in structured populations. Am J Hum Genet 2000;67:170-81.
58. Thakkinstian A, McElduff P, D'Este C, et al. A method for meta-analysis of molecular association studies. Stat Med 2004;24:1291-306.
59. Attia J, Thakkinstian A, D'Este C. Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol 2003;56:297-303.
60. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996;273:1516-17.
61. Altshuler D, Kruglyak L, Lander E. Genetic polymorphisms and disease. (Letter). N Engl J Med 1998;338:1626.
62. Dahlman I, Eaves IA, Kosoy R, et al. Parameters for reliable results in genetic association studies in common disease. Nat Genet 2002;30:149-50.
63. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995;11:241-7.
64. Wacholder S, Chanock S, Garcia-Closas M, et al. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004;96:434-42.
65. Ioannidis JP. Why most published research findings are false. PLoS Med 2005;2(8):e124. (DOI: 10.1371/journal.pmed. 0020124).
66. Ioannidis JP, Trikalinos TA. Early extreme contradictory estimates may appear in published research: the Proteus phenomenon in molecular genetics research and randomized trials. J Clin Epidemiol 2005;58:543-9.
67. Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG, et al. Establishment of genetic associations for complex diseases is independent of early study findings. Eur J Hum Genet 2004;12:762-9.
68. Lau J, Ioannidis JP, Schmid CH. Summing up evidence: one answer is not always enough. Lancet 1998;351:123-7.
69. Sasieni PD. From genotypes to genes: doubling the sample size. Biometrics 1997;53:1253-61.